# Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors

> **NCT07375290** · PHASE1 · RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 20 (estimated)

## Conditions studied

- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** Zoledronate

## Key facts

- **NCT ID:** NCT07375290
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2028-01
- **Final completion:** 2028-11
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07375290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07375290, "Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT07375290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*